Adalimumab, Citrate Free

CHEBI:CHEBI_753780

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

listing_expiration_date
20251231
dosage_form
LIQUID
active_ingredient_strength
140 mg/mL
product_type
DRUG FOR FURTHER PROCESSING
marketing_category
DRUG FOR FURTHER PROCESSING
marketing_start_date
20181106
package_marketing_start_date
06-NOV-18
labeler_name
Lonza Biologics Tuas Pte Ltd.
generic_name
Adalimumab, Citrate Free
product_ndc
69438-0010
spl_id
1bdbce7a-53c4-fe77-e063-6394a90a5e70
active_ingredient_name
ADALIMUMAB (HUMIRA)
package_ndc
69438-0010-2
package_description
2000 mL in 1 BOTTLE (69438-0010-2)
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class